Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103262-35-7

Post Buying Request

103262-35-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103262-35-7 Usage

General Description

2,3-Dihydro-1-benzofuran-5-ylmethanol, also known as DHBM, is a chemical compound with a molecular formula C9H10O2. It is a white to off-white solid with a melting point of 97-99°C. DHBM is commonly used in the synthesis of various pharmaceutical and agrochemical compounds, as well as in the production of fragrances and flavors. This chemical is also known for its potential biological activities, including anti-inflammatory and anticancer properties. DHBM is a versatile building block in organic synthesis and is widely used in the pharmaceutical and chemical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 103262-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,2,6 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 103262-35:
(8*1)+(7*0)+(6*3)+(5*2)+(4*6)+(3*2)+(2*3)+(1*5)=77
77 % 10 = 7
So 103262-35-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O2/c10-6-7-1-2-9-8(5-7)3-4-11-9/h1-2,5,10H,3-4,6H2

103262-35-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (2,3-Dihydrobenzofuran-5-yl)methanol

1.2 Other means of identification

Product number -
Other names 2,3-DIHYDRO-1-BENZOFURAN-5-YLMETHANOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103262-35-7 SDS

103262-35-7Relevant articles and documents

Benzopentaoxyheterocycle-benzimidazole salt compounds, and synthesis method and application thereof

-

Paragraph 0034; 0172-0176; 0185-0189, (2019/11/04)

The invention discloses benzopentaoxyheterocycle-benzimidazole salt compounds, and a synthesis method and an application thereof, and belongs to the technical field of medicinal chemistry. The structural formula of the benzopentaoxyheterocycle-benzimidazole salt compounds is shown in the description. In the formula, when X is O and Y is CH2, R and R are H, and R is a 2-naphthoylmethyl group, or R is CH3, R is H, and R is a 2-naphthoylmethyl group, a 4-bromobenzyl, a 2-naphthylmethyl group, a 4-methylbenzyl group or a 2-bromobenzyl group; when X is CH2 and Y is C-O, R and R are H, and R is a 2-naphthoylmethyl group, or R is CH3, R is H, and R is a 2-naphthoylmethyl group, or R is H, R is CH3, and R is a 2-naphthoylmethyl group or a 2-bromobenzylgroup; and when X is CH2 and Y is CH2, R is H, R is CH3, and R is a 2-naphthoylmethyl group or a 2-bromobenzyl group. Medicines prepared from the compounds of the invention and at least one pharmaceutically acceptable excipient, diluent or carrier can be used for tumor cancers.

PYRIMIDINE-5-CARBOXAMIDE COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF

-

, (2008/06/13)

A compound of the formula wherein R1 is a heterocycle having a skeleton consisting of 3 to 15 atoms including 1 to 5 nitrogen atom(s), which heterocycle is attached by a secondary nitrogen atom constituting the heterocycle; X is an oxygen atom, a nitrogen atom optionally substituted by a hydrocarbon group having 1 to 5 carbon atom(s) or a sulfur atom optionally oxidized with 1 or 2 oxygen, Y is a bond or a C1-5 alkylene group, R2 is (1) a hydrogen atom, (2) a hydroxy group, (3) a C1-5 alkoxy group, (4) a C1-5 alkylthio group, (5) a carbocycle having 3 to 15 carbon atoms or (6) a heterocycle having a skeleton consisting of 3 to 15 atoms including 1 to 5 heteroatom(s), provided that when Y is a bond, R2 is a carbocycle having 3 to 15 carbon atoms or a heterocycle having a skeleton consisting of 3 to 15 atoms including 1 to 5 heteroatom(s) and; one of R3 and R4 is a hydrogen atom or a group of the formula: -Z-R5 (Z is a bond or C1-10 alkylene group optionally having substituent(s) and R5 is (1) a hydrogen atom, (2) a hydroxy group, (3) a C1-5 alkoxy group, (4) a nitrile group, (5) a C1-5 alkoxy-carbonyl group, (6) a carboxyl group, (7) a carbamoyl group, (8) a (mono or di-C1-5 alkyl)carbamoyl group, (9) an amino group, (10) a (di or mono-C1-5 alkyl)amino group, (11) a (C1-5 alkoxy-carbonyl)amino group, (12) a C1-5 alkylthio group, (13) a carbocycle having 3 to 15 carbon atoms or (14) a heterocycle having a skeleton consisting of 3 to 15 atoms including 1 to 5 heteroatom(s)); the other is a group of the formula: -Z-R5 (Z and R5 are as defined above); and R3 and R4 may form, together with the adjacent nitrogen atom, a heterocycle having a skeleton consisting of 3 to 15 atoms, which heterocycle is attached by a secondary nitrogen atom constituting the heterocycle, wherein the above-mentioned heterocycle and a carbocycle having 3 to 15 carbon atoms are each optionally substituted by substituent(s) selected from the group consisting of C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C7-16 aralkyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, C6-14 aryl, C1-8 alkoxy, C1-3 alkylenedioxy, hydroxy, halogen atom, amino, (di or mono-C1-5 alkyl)amino, (C1-5 alkoxy-carbonyl)amino, (C1-5 acyl)amino, (C1-5 acyl) (C1-5 alkyl)amino, C1-5 alkylthio, nitrile, nitro, C1-5 alkoxy-carbonyl, carboxyl, C1-5 alkyl-carbonyloxy, oxo, thioxo, C1-6 acyl group, sulfamoyl and (di or mono-C1-5 alkyl)sulfamoyl, or a salt thereof or a prodrug thereof have a superior cGMP specific phosphodiesterase (PDE) inhibitory activity, and can be used as an agent for the prophylaxis or treatment of cardiovascular diseases such as angina pectoris, heart failure, cardiac infarction, hypertension, arteriosclerosis and the like, allergic diseases such as asthma, or disorders of male or female genital function and the like.

Tricyclic compounds, their production and use

-

, (2008/06/13)

A compound of the formula: STR1 wherein R1 is an optionally substituted hydrocarbon, amino or heterocyclic group; R2 is H or an optionally substituted hydrocarbon group; R3 is H or an optionally substituted hydrocarbon or heterocyclic group; X is CHR4, NR4, O or S in which R4 is H or an optionally substituted hydrocarbon group; Y is C, CH or N; ring A is optionally substituted 5- to 7-membered ring; ring B is an optionally substituted benzene ring; and m is 1 to 4, or a salt thereof, a process for producing it, an intermediate for the production and a pharmaceutical composition comprising it are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103262-35-7